Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
308
-
Total 13F shares, excl. options
-
205,149,902
-
Shares change
-
+27,807,882
-
Total reported value, excl. options
-
$7,270,055,685
-
Value change
-
+$1,020,157,424
-
Put/Call ratio
-
35%
-
Number of buys
-
199
-
Number of sells
-
99
-
Price
-
$35.44
Institutional Holders of IMMUNOMEDICS INC - COM (IMMU) as of Q2 2020
As of 30 Jun 2020 IMMUNOMEDICS INC - COM (IMMU) had 308 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 205,149,902 shares of stock of the company.
Largest 10 holders included Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BOXER CAPITAL, LLC, Palo Alto Investors LP, ALKEON CAPITAL MANAGEMENT LLC, RP Management, LLC, and Point72 Asset Management, L.P..
This table shows 308 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.